Post-approval studies (Phase 4)UnknownNCT00838019What this trial is testingIntrabone Cord Blood TransplantationWho this might be right forHematological Malignancies Hospital Clinic of Barcelona 10
Not applicableLooking for participantsNCT06509945What this trial is testingAllo-PBSCT as the First-line Treatment for Patients With the High-risk PTCLWho this might be right forPeripheral T Cell Lymphoma Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT00223730What this trial is testingChemotherapy Toxicity Reduction Via Urea Cycle SupportWho this might be right forCancer Vanderbilt University 100
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Testing effectiveness (Phase 2)Ended earlyNCT02504619What this trial is testingAllogeneic SCT of CordIn™, in Patients With HemoglobinopathiesWho this might be right forSickle Cell DiseaseThalassemia Gamida Cell ltd 1
Testing effectiveness (Phase 2)Study completedNCT00048412What this trial is testingStem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1HWho this might be right forMyelodysplastic DisordersLeukemiaMultiple Myeloma+2 more Baylor College of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT00925821What this trial is testingLenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple MyelomaWho this might be right forMultiple Myeloma Wuerzburg University Hospital 146
Testing effectiveness (Phase 2)Study completedNCT01814488What this trial is testingA Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute LeukemiaWho this might be right forAcute Leukemia Gruppo Italiano Trapianto di Midollo Osseo 101
Not applicableStudy completedNCT03642977What this trial is testingDNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant RecipientsWho this might be right forHematopietic Stem Cell TransplantationBlood ViromeRNA Virus Infections+1 more University Hospital, Geneva 112
Testing effectiveness (Phase 2)Study completedNCT00636909What this trial is testingNonmyeloablative Allo SCT for the Treatment of Hematologic DisordersWho this might be right forAMLALLCML Chronic Phase, Accelerated Phase, or Blast Crisis+6 more Beth Israel Deaconess Medical Center 25
Early research (Phase 1)Study completedNCT00060372What this trial is testingIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more National Cancer Institute (NCI) 21
Not applicableStudy completedNCT03401268What this trial is testingSubcutaneous Ig in Allogeneic Stem Cell Transplant RecipientsWho this might be right forHypogammaglobulinemia University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT00612716What this trial is testingDonor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm Masonic Cancer Center, University of Minnesota 6
Not applicableEnded earlyNCT00008216What this trial is testingBlood Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAdult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more Columbia University 48
Early research (Phase 1)Study completedNCT01163357What this trial is testingBortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple MyelomaWho this might be right forAutologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more City of Hope Medical Center 18
Early research (Phase 1)Study completedNCT00001765What this trial is testingStem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous DiseaseWho this might be right forChronic Granulomatous Disease National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT00462878What this trial is testingMeropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell TransplantationWho this might be right forAllogenic Blood Stem Cell TransplantationFebrile Neutropenia PETHEMA Foundation 392
Testing effectiveness (Phase 2)UnknownNCT02083718What this trial is testingPeripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft FunctionWho this might be right forStem Cell Transplantation, HematopoieticPoor Graft FunctionHematological Diseases Nanfang Hospital, Southern Medical University 120
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Early research (Phase 1)WithdrawnNCT03807063What this trial is testingRivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell TransplantWho this might be right forAcute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more Fred Hutchinson Cancer Center